Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

ClinicalTrials.gov ID: NCT00002427

Public ClinicalTrials.gov record NCT00002427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of the Safety and Antiretroviral Activity of Nine Hydroxyurea Regimens in Combination With ddI and d4T in Subjects With HIV Infection

Study identification

NCT ID
NCT00002427
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Research Institute for Genetic and Human Therapy
Other
Enrollment
225 participants

Conditions and interventions

Conditions

Interventions

  • Hydroxyurea Drug
  • Stavudine Drug
  • Didanosine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 1999
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

Started 1999

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
AIDS Healthcare Foundation Los Angeles California 90027
San Francisco VA Med Ctr San Francisco California 94121
Gary Blick MD Stamford Connecticut 06901
Dr Bruce Rashbaum Washington D.C. District of Columbia 20037
IDC Research Initiative Altamonte Springs Florida 32701
Boulevard Comprehensive Care Ctr Jacksonville Florida 32209
Center for Quality Care Tampa Florida 33609
AIDS Research Consortium of Atlanta Inc Atlanta Georgia 30308
New England Med Ctr Boston Massachusetts 02111
Albany Med College Albany New York 122083479
Mt Vernon Hosp Mount Vernon New York 10550
Univ of Pennsylvania Med Ctr Philadelphia Pennsylvania 19104
Thomas Jefferson Univ Philadelphia Pennsylvania 19107
Coastal Carolina Research Ctr Mt. Pleasant South Carolina 29464
Univ of Texas Southwestern Med Ctr of Dallas Dallas Texas 75235
Univ of Texas Med Branch Galveston Texas 775550835
Montrose Clinic Houston Texas 77006
Swedish Med Ctr Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002427 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →